Amplitude Healthcare Acquisition Corp

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Amplitude Healthcare Acquisition Corp
TickerJSPR
CIK #0001788028
CUSIP471871202
SectorReal Estate & Construction - Blank Checks
Address1177 Avenue of The Americas Fl 40, New York, NY 10036
Source [EDGAR]
CIK Filing 2011 - 2026
[0001788028] 10-K
[0001788028] 10-Q
[0001788028] 3
[0001788028] 4
[0001788028] 8-K
[0001788028] SC 13D
[0001788028] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Integrated Core Strategies US LLC Jasper Therapeutics Inc [2026-02-25] 0.0
Goldman Sachs Group Inc Jasper Therapeutics Inc [2026-02-12] 0.0
Morgan Stanley Jasper Therapeutics Inc [2026-02-11] 0.0
Acorn BioVentures LP Jasper Therapeutics Inc [2025-12-02] 0.0
T Rowe Price Investment Management Inc Jasper Therapeutics Inc [2025-11-14] 0.0
Morgan Stanley Jasper Therapeutics Inc [2025-08-06] 0.0
Kingdon Capital Management LLC Jasper Therapeutics Inc [2025-07-11] 0.0
BlackRock Inc Jasper Therapeutics Inc [2024-11-08] 5.3
BlackRock Inc Jasper Therapeutics Inc [2024-10-22] 5.3
Avidity Partners Management LP Jasper Therapeutics Inc [2024-03-27] 5.1
Sphera Funds Management Ltd Jasper Therapeutics Inc [2023-10-10] 5.13
Velan Capital Investment Management LP Jasper Therapeutics Inc [2023-02-27] 7.7
Biotechnology Value Fund L P Jasper Therapeutics Inc [2023-02-06] 4.8
Soleus Capital Master Fund LP Jasper Therapeutics Inc [2023-01-30] 5.7
Abingworth LLP Jasper Therapeutics Inc [2021-10-04] 15.4
Citadel Advisors LLC Jasper Therapeutics Inc [2021-10-04] 0.8
Amplitude Healthcare Holdings LLC Jasper Therapeutics Inc [2021-10-04] 6.3
Roche Finance Ltd Jasper Therapeutics Inc [2021-10-04] 12.7
Avego Management LLC Jasper Therapeutics Inc [2021-10-04] 6.7
Amgen Inc Jasper Therapeutics Inc [2021-10-01] 9.0
Qiming US Healthcare Fund II LP Jasper Therapeutics Inc [2021-10-01] 16.0
Beryl Capital Management LLC Amplitude Healthcare Acquisition Corp [2021-09-17] 6.5
Glazer Capital LLC Amplitude Healthcare Acquisition Corp [2020-09-10] 11.2
UBS OConnor LLC Amplitude Healthcare Acquisition Corp [2020-02-13] 5.5
Amplitude Healthcare Holdings LLC Amplitude Healthcare Acquisition Corp [2020-02-13] 20.0
Tenor Capital Management Co LP Amplitude Healthcare Acquisition Corp [2020-01-31] 7.59
Owl Creek Asset Management LP Amplitude Healthcare Acquisition Corp [2019-12-02] 4.8
Form 3/4/5 Filer 2011 - 2026
Mahal Jeetinder Singh
Amplitude Healthcare Acquisition Corp
Cross Herb
Martell Ron
Shizuru Judith Anne
Kapoor Vishal
Wiggans Thomas G
Brun Scott C
Emster Kurt von
Nolet Chris
Lucas Svetlana
Tucker Edwin Jonathan
French Anna Louise
Carlyle Genesis UK LLC
Carlyle Holdings I GP Sub LLC
Carlyle Investment Management LLC
Carlyle Group Inc
Carlyle Holdings I GP Inc
CG Subsidiary Holdings LLC
Abingworth BioVentures VII LP
Carlyle Holdings I LP
Abingworth LLP
TC Group LLC
Velan Capital Investment Management LP
Avego Management LLC
Morgan Adam
Avego Healthcare Capital Holdings LLC
Venkataraman Balaji
Velan Capital Management LLC
Avego Healthcare Capital LP
Velan Capital Master Fund LP
Velan Capital Holdings LLC
Lis William
Klein Lawrence Otto
Qiming US Healthcare Fund II LP
McDade Mark
Rieschel Gary E
Qiming US Healthcare GP II LLC
Roche Holding Ltd
Roche Finance Ltd
Heller Kevin N
Clifford Kenneth F
Hoffen Howard I
Amplitude Healthcare Holdings LLC
Glazer Paul J
Glazer Capital LLC
Dolan Peter R
Eshelman Fredric N
Mario Ernest
Reicin Glenn
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Mahal Jeetinder Singh
Stock Option (right to buy) · derivative
2026-02-06 Grant 500,000 $0.00
Martell Ron
Stock Option (right to buy) · derivative
2026-01-02 Grant 234,000 $0.00
Mahal Jeetinder Singh
Stock Option (right to buy) · derivative
2026-01-02 Grant 90,000 $0.00
Cross Herb
Stock Option (right to buy) · derivative
2026-01-02 Grant 90,000 $0.00
Voting Common Stock
2025-09-22 Buy 41,000 $2.43 99,630
Voting Common Stock
2025-09-22 Buy 20,000 $2.43 48,600
Voting Common Stock
2025-09-22 Buy 41,000 $2.43 99,630
Voting Common Stock
2025-09-22 Buy 41,000 $2.43 99,630
Common Stock Warrant (right to buy) · derivative
2025-09-22 Buy 41,000
Common Stock Warrant (right to buy) · derivative
2025-09-22 Buy 20,000
Common Stock Warrant (right to buy) · derivative
2025-09-22 Buy 41,000
Common Stock Warrant (right to buy) · derivative
2025-09-22 Buy 41,000
Brun Scott C
Stock Option (right to buy) · derivative
2025-07-03 Grant 7,500 $0.00
Emster Kurt von
Stock Option (right to buy) · derivative
2025-07-03 Grant 7,500 $0.00
Shizuru Judith Anne
Stock Option (right to buy) · derivative
2025-07-03 Grant 7,500 $0.00
Nolet Chris
Stock Option (right to buy) · derivative
2025-07-03 Grant 7,500 $0.00
Kapoor Vishal
Stock Option (right to buy) · derivative
2025-07-03 Grant 7,500 $0.00
Wiggans Thomas G
Stock Option (right to buy) · derivative
2025-07-03 Grant 7,500 $0.00
Lucas Svetlana
Stock Option (right to buy) · derivative
2025-07-03 Grant 7,500 $0.00
Martell Ron
Stock Option (right to buy) · derivative
2025-06-04 Grant 234,000 $0.00
showing 20 of 157 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 59 15,966,460
2025-12-31 56 18,838,442
2025-09-30 60 19,241,959
2025-06-30 66 11,910,889
2025-03-31 70 12,399,595
2024-12-31 92 16,053,288
2024-09-30 82 14,954,579
2024-06-30 71 14,744,285
2024-03-31 62 13,506,469
2023-12-31 43 80,771,192
2023-09-30 42 91,616,802
2023-06-30 50 88,197,706
Form 13F Holdings
Firm Period DFND Voting Shares
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com